Psoriasiform drug eruption due to abatacept

Acta Dermato-Venereologica

Volumn 91, Issue 3, 2011, Pages 362-363

  Kato, Kohei ^a   Satoh, Takahiro ^a   Nishizawa, Aya ^a   Yokozeki, Hiroo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CORTICOSTEROID; IMMUNOGLOBULIN G; METHOTREXATE; PREDNISOLONE; RHEUMATOID FACTOR; STROMELYSIN;

ACANTHOSIS; ADULT; CASE REPORT; CELL INFILTRATION; CORTICOSTEROID THERAPY; DERMIS; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG ERUPTION; EPIDERMIS; ERYTHEMA; FEMALE; FOOT SOLE; HAND PALM; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LETTER; LEUKOCYTE COUNT; LIMB; MICROSCOPY; MONONUCLEAR CELL; NEUTROPHIL; PATCH TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; REMISSION; RHEUMATOID ARTHRITIS;

ADRENAL CORTEX HORMONES; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOCONJUGATES; MIDDLE AGED; PSORIASIS; SKIN; TREATMENT OUTCOME;

EID: 79955715329     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1042     Document Type: Letter

References (7)

1. Vital EM, Emery P. Abatacept in the treatment of rheumatoid arthritis. Ther Clin Risk Manag 2006; 2: 365-375.
2. Brunasso AM, Laimer M, Massone C. Paradoxical reactions to targeted biological treatments: A way to treat and trigger? Acta Derm Venereol 2010; 90: 183-185.
3. Kuhara T, Watanabe D, Iwahori Y, Tamada Y, Yamamura M, Matsumoto Y. Psoriasiform and pustular eruption induced by etanercept and infiximab. Eur J Dermatol 2009; 19: 388-389.
4. Seneschal J, Milpied B, Vergier B, Lepreux S, Schaeverbeke T, Taieb A. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 2009; 161: 1081-1088.
5. Collamer AN, Guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum 2008; 59: 996-1001.
6. Golmia A, Grinblat B, Finger E, Klieman C, Assir F, Schein-berg M. The development of erythema elevatum diutinum in a patient with juvenile idiopathic arthritis under treatment with abatacept. Clin Rheumatol 2008; 27: 105-106.
7. Jain N, Nguyen H, Chambers C, Kang J. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proc Natl Acad Sci USA 2010; 107: 1524-1528.